Volume 19 Supplement 1

35th International Symposium on Intensive Care and Emergency Medicine

Open Access

Normobaric oxygen paradox and erythropoietin production in critically ill patients: a prospective observational study

  • S Zuccari1,
  • A Donati1,
  • E Damiani1,
  • R Castagnani1,
  • N Mininno1 and
  • P Pelaia1
Critical Care201519(Suppl 1):P320

https://doi.org/10.1186/cc14400

Published: 16 March 2015

Introduction

The normobaric oxygen paradox (NOP) postulates that a period of normobaric hyperoxia followed by a rapid return to normoxia will create a condition of relative hypoxia, which acts in turn as a stimulus for erythropoietin (EPO) production [1]. Variations in GSH and oxygen free radical (ROS) levels may be involved in this process. We tested the NOP in critically ill patients.

Methods

A prospective observational study on 38 mechanically ventilated (FiO2 <50%) patients with no active bleeding, no blood transfusion needed, and no kidney failure. Eighteen patients underwent a 2-hour period of normobaric hyperoxia (FiO2 = 100%), 20 patients were evaluated as controls (no FiO2 variations). EPO was assayed at baseline (t0), 24 hours (D1) and 48 hours (D2). Serum GSH and ROS were assayed at t0 (baseline), t1 (2-hour FiO2 100%) and t2 (2hour return to normoxia) in 12 patients in the hyperoxia group.

Results

EPO tended to increase in the hyperoxia group over time (P = 0.05), while it remained stable in the control group (P = 0.53) (Figure 1). ROS levels increased at t1 and decreased at t2, GSH tended to decrease at t1 and increased at t2 in the hyperoxia group.

Figure 1

Conclusion

Relative hypoxia after a transient period of normobaric hyperoxia induces an increase in GSH levels, thus enhancing ROS scavenging. This may act as a stimulus for EPO production.

Authors’ Affiliations

(1)
Università Politecnica delle Marche

References

  1. Balestra , et al: J Appl Physiol. 2006, 100: 512-8. 10.1152/japplphysiol.00964.2005.View ArticlePubMedGoogle Scholar

Copyright

© Zuccari et al.; licensee BioMed Central Ltd. 2015

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement